483
Smithfield Bioscience IncFDA 483 - Smithfield Bioscience Inc - October 27, 2016
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Celsus Laboratories Inc. in Cincinnati, OH, received a Form 483 citing significant deficiencies in laboratory computer system validation, electronic data oversight, and testing procedures. The inspection also found issues with document control for production batch records, indicating a lack of robust quality unit controls. These observations highlight concerns regarding data integrity and adherence to established manufacturing practices for an API manufacturer.
Open in Dashboard
ID · 526e561f-ce17-421d-9327-52d8c6ce2b8a